Related references
Note: Only part of the references are listed.Endocannabinoid system in psychotic and mood disorders, a review of human studies
Ranjini Garani et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System
Ana Lago-Fernandez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation
Fabio Arturo Iannotti et al.
CELLS (2021)
Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease
Estefania Moreno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Adiposity in schizophrenia: A systematic review and meta-analysis
Emily Smith et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases
Bryan Latrell Holloman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of the Endocannabinoid System in the Adipose Tissue with Focus on Energy Metabolism
Volatiana Rakotoarivelo et al.
CELLS (2021)
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids
E. Appiah-Kusi et al.
PSYCHOLOGICAL MEDICINE (2020)
Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis
Liisa Leppik et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)
A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity
Helda Tutunchi et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2020)
Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting
Stephane Potvin et al.
FRONTIERS IN PSYCHIATRY (2020)
Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease
Madis Parksepp et al.
SCIENTIFIC REPORTS (2020)
Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis
Alex M. Dickens et al.
NPJ SCHIZOPHRENIA (2020)
Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia
Yuina Wada et al.
EBIOMEDICINE (2020)
Statistical significance: p value, 0.05 threshold, and applications to radiomics-reasons for a conservative approach
Giovanni Di Leo et al.
EUROPEAN RADIOLOGY EXPERIMENTAL (2020)
Management of Metabolic Syndrome in Schizophrenia
Pragyan Sharma et al.
PSYCHIATRIC ANNALS (2020)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Measuring Disturbance of the Endocannabinoid System in Psychosis A Systematic Review and Meta-analysis
Amedeo Minichino et al.
JAMA PSYCHIATRY (2019)
Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments
Courtney R. Sullivan et al.
MOLECULAR NEUROBIOLOGY (2019)
Antipsychotic treatment is associated with inflammatory and metabolic biomarkers alterations among first-episode psychosis patients: A 7-month follow-up study
Roman Balotsev et al.
EARLY INTERVENTION IN PSYCHIATRY (2019)
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2019)
Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: A systematic review and meta-analysis
Padraig Oakley et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and Liver
Laura B. Ferguson et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Involvement of TRPV1 Channels in Energy Homeostasis
Stewart Christie et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
Kazuhito Tsuboi et al.
INFLAMMATION AND REGENERATION (2018)
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
Stefania Petrosino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine
Isabelle Kohler et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment
Kart Kriisa et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Evidence for altered cell membrane lipid composition in postmortem prefrontal white matter in bipolar disorder and schizophrenia
Sanjoy Ghosh et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Oleic acid-derived oleoylethanolamide: A nutritional science perspective
Kate J. Bowen et al.
PROGRESS IN LIPID RESEARCH (2017)
Impaired Glucose Homeostasis in First-Episode Schizophrenia A Systematic Review and Meta-analysis
Toby Pillinger et al.
JAMA PSYCHIATRY (2017)
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes
Dai Lu et al.
CELL STRESS & CHAPERONES (2016)
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia
Mohini Ranganathan et al.
BIOLOGICAL PSYCHIATRY (2016)
Fatty acids, endocannabinoids and inflammation
Renger Witkamp
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis
Benjamin Ian Perry et al.
LANCET PSYCHIATRY (2016)
Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index
Liina Haring et al.
SCHIZOPHRENIA RESEARCH (2015)
The endocannabinoid system: directing eating behavior and macronutrient metabolism
Bruce A. Watkins et al.
FRONTIERS IN PSYCHOLOGY (2015)
Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands
Marco Fidaleo et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Endocannabinoids, Related Compounds and Their Metabolic Routes
Filomena Fezza et al.
MOLECULES (2014)
Plasma Concentrations of Endocannabinoids and Related Primary Fatty Acid Amides in Patients with Post-Traumatic Stress Disorder
Daniela Hauer et al.
PLOS ONE (2013)
Regulation of GPR119 receptor activity with endocannabinoid-like lipids
Samreen K. Syed et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: Minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction
Alexander A. Zoerner et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans
Andrea Dlugos et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia
Joëlle Desfossés et al.
Frontiers in Psychiatry (2012)
Obesity and the Endocannabinoid System: Circulating Endocannabinoids and Obesity
Isabelle Matias et al.
CURRENT OBESITY REPORTS (2012)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Interaction between cytokines, cannabinoids and the nervous system
Lucie Jean-Gilles et al.
IMMUNOBIOLOGY (2010)
Sterol Regulatory Element Binding Proteins (SREBPs): Controllers of Lipid Synthesis and Cellular Uptake
Michael S. Brown et al.
NUTRITION REVIEWS (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Endogenous cannabinoid signaling is essential for stress adaptation
Matthew N. Hill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Endocannabinoids and Schizophrenia
Joelle Desfosses et al.
PHARMACEUTICALS (2010)
Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease
Jean-Charles Fruchart
ATHEROSCLEROSIS (2009)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Schizophrenia, just the facts 4. Clinical features and conceptualization
Rajiv Tandon et al.
SCHIZOPHRENIA RESEARCH (2009)
Wiring and firing neuronal networks: endocannabinoids take center stage
Tibor Harkany et al.
CURRENT OPINION IN NEUROBIOLOGY (2008)
Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia
Kirsten R Müller-Vahl et al.
Expert Review of Neurotherapeutics (2008)
GPR55: a new member of the cannabinoid receptor clan?
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Science and society - Cannabis, the mind and society: the hash realities
Robin M. Murray et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients:: Impact of cannabis use
F. Markus Leweke et al.
SCHIZOPHRENIA RESEARCH (2007)
Cannabinoids: A New Group of Agonists of PPARs
Yan Sun et al.
PPAR RESEARCH (2007)
Biochemistry and pharmacology of endovanilloids
Katarzyna Starowicz et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Cannabinoid signalling
DG Demuth et al.
LIFE SCIENCES (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Cannabinoid receptors and their role in neuroprotection
M van der Stelt et al.
NEUROMOLECULAR MEDICINE (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
The endocannabinoid system: a general view and latest additions
L De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
A Giuffrida et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Heterosynaptic LTD of hippocampal GABAergic synapses: A novel role of endocannabinoids in regulating excitability
V Chevaleyre et al.
NEURON (2003)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Nuclear receptors and lipid physiology: Opening the X-files
A Chawla et al.
SCIENCE (2001)
Share Paper
